Follow tonight's NBA action as we keep you updated with the latest highlights and happenings around the league. NBA.com Staff ORLANDO, FLORIDA – FEBRUARY 26: Kevin Durant #7 of the Houston Rockets ...

(1) Includes related party accounts receivable of $2.5 million as of December 31, 2025 and December 31, 2024, respectively. (2) Includes related party liabilities of $5.7 million and $1.7 million as ...

Announced positive topline results from TX45 Phase 1b acute hemodynamic clinical trial in patients with Group 2 Pulmonary Hypertension in Heart Failure with reduced Ejection Fraction (“PH-HFrEF”) in ...

Established partnership with Kelun-Biotech expanding pipeline and accelerating combination strategy with CR-001, PD-1 x VEGF bispecific antibody, and multiple ADCs ASCEND Phase 1/2 global clinical ...

eClinical Solutions LLC, a global provider of digital clinical software and services, today announced 2025 milestones along with new 2026 innovation to support the end-to-end clinical research ...

Cemsidomide Advancing into Later-stage Development with Potential for Accelerated Approval; First Patient Dosed in the Phase 2 MOMENTUM Trial for Multiple Myeloma in the Fourth Line or Later Phase 1b ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today ...

Financial Highlights Total revenue: Total revenue for the fourth quarter 2025 was $114.6 million, representing 25% growth compared to total revenue of $91.8 million for the fourth quarter 2024. Total ...

Positive results from the aleniglipron Phase 2 ACCESS programs in December 2025 demonstrated significant weight loss across all doses and up to 15.3% at 36 weeks Topline 44-week data from the ACCESS ...

Welcome to Recaptured — a weekly roundup of The Daily’s photojournalism, featuring our reporters’ most memorable moments. This week’s Recaptured includes a Men’s Basketball win against Maryland, a Q&A ...